双鹭药业：长效促卵泡审评暂停是因到达审评时限，目前在等待发补意见

Core Viewpoint - The review of the long-acting follicle-stimulating hormone has been suspended due to reaching the review deadline, and the company is currently awaiting supplementary comments [1] Company Summary - 双鹭药业 (Shuanglu Pharmaceutical) has communicated with investors regarding the status of its long-acting follicle-stimulating hormone review process [1]